Sign in
4

Changes in Ownership

ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-107141

Chief Financial Officer gave up 6,263 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Myszkowski Kenneth Allen · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-03-04 Shares withheld for taxes : show line 1 in the form −6,263 $4.33 $27,119 115,689 D
Loading xslF345X03/doc4.xml…